Burden of Disease: Psoriasis and Psoriatic Arthritis
- 15 June 2013
- journal article
- review article
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 14 (5) , 377-388
Abstract
Psoriatic arthritis (PsA) increases the disease burden associated with psoriasis by further diminishing quality of life, increasing health care costs and cardiovascular risk, and potentially causing progressive joint damage. The presence of PsA influences psoriasis treatment by increasing overall disease complexity and, within the framework of current guidelines and recommendations, requiring the use of conventional disease-modifying anti-rheumatic drugs or tumor necrosis factor-α inhibitors in order to prevent progressive joint damage. Despite its important impact, PsA is still under-diagnosed in dermatology practice. Dermatologists are well positioned to recognize and treat PsA, given that it characteristically presents, on average, 10 years subsequent to the appearance of skin symptoms. Regular screening of psoriasis patients for early evident joint symptoms should be incorporated into daily dermatologic practice. Although drugs effective in PsA are available, not all patients may respond to treatment, and others may lose their initial response over time. New investigational therapies, such as inhibitors of interleukin-17A, interleukin-12/23, Janus kinase 3, or phosphodiesterase-4, may address unmet needs in psoriatic disease, with further research needed to determine the role of these agents in reducing joint damage and other comorbidities.Keywords
This publication has 83 references indexed in Scilit:
- High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnairesAnnals of the Rheumatic Diseases, 2013
- Psoriatic Arthritis: An UpdateArthritis, 2012
- Psoriatic arthritis: from a dermatological perspectiveEuropean Journal Of Dermatology, 2011
- Psoriatic arthritis – what the dermatologist needs to knowJournal of the European Academy of Dermatology and Venereology, 2010
- Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literatureJournal of the European Academy of Dermatology and Venereology, 2010
- The Burden of Psoriasis in Canada: Insights from the pSoriasis Knowledge IN Canada (SKIN) SurveyJournal of Cutaneous Medicine and Surgery, 2009
- Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasisBritish Journal of Dermatology, 2009
- Guidelines of care for the management of psoriasis and psoriatic arthritisJournal of the American Academy of Dermatology, 2008
- Determinants of quality of life in patients with psoriasis: A study from the US populationJournal of the American Academy of Dermatology, 2004
- Quality of Life and Prevalence of Arthritis Reported by 5,795 Members of the Nordic Psoriasis AssociationsActa Dermato-Venereologica, 2002